New Phenomenex Gas Chromatography Management Filters and Inline Gas Trap

Torrance, Calif. (July, 31 2019) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces the New Zebron™ Gas Management Filters and Click-on Inline Gas Trap, which removes contaminants from carrier gas to reduce gas chromatography system downtime and column damage and deliver pure gas for... Read more

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Genome Canada, Ontario Institute for Cancer Research and Thermo Fisher Scientific to focus on pancreatic, prostate and breast cancer CARLSBAD, Calif., July 30, 2019 /PRNewswire/ — Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation sequencing (NGS) assays and analysis... Read more

Phenomenex, Inc. Announces New Solid Phase Extraction for Significant Sample Preparation Time Savings

07/30/2019 Phenomenex Inc., a global leader in the research, design, and manufacture of advanced technologies for the separation sciences, introduces Strata®-X PRO Solid Phase Extraction (SPE) Tubes and 96-Well Plates. Strata-X PRO consists of a new type of polymeric SPE sorbent combined with matrix removal technology to revolutionize sample extractions and matrix clean-up. While traditional... Read more

Waters Improves and Extends Tandem Quadrupole MS Portfolio with Upgraded Xevo TQ-S Micro and New Xevo TQ-S Cronos

Designed for Quantitative Analysis, Waters Full Portfolio of TQ MS Systems Make High Performance and Routine Analysis Accessible, Robust, Reliable. MILFORD, Mass.–(BUSINESS WIRE)–Jul. 29, 2019– Waters Corporation (NYSE:WAT) today reinforced its tandem quadrupole mass spectrometry portfolio with upgrades to the Xevo™ TQ-S micro and the introduction of the new Xevo TQ-S cronos. This press release features multimedia. View the... Read more

PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market

Combines PerkinElmer’s expertise in immunodiagnostic testing and state-of-the-art genomics program with EverlyWell’s consumer health offerings WALTHAM, Massachusetts, and AUSTIN, Texas – July 24, 2019 – Today, PerkinElmer, Inc. and EverlyWell, Inc. announced a new collaboration designed to accelerate innovation in and accessibility of consumer-initiated health testing, by adding PerkinElmer’s CLIA-certified and CAP-accredited lab facilities to... Read more

Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast

BILLERICA, Mass., July 23, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2019 financial results on Thursday, August 1, 2019, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.  To listen to the... Read more

Merck KGaA, Darmstadt, Germany and Broad Institute Announce CRISPR License Framework to Encourage Innovation

18 JUL 2019 | DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the Broad Institute of MIT and Harvard today announced an agreement between Broad Institute and the Life Science business of Merck KGaA, Darmstadt, Germany to offer non-exclusive licenses... Read more

Illumina Expands Genomics Accelerator to Cambridge, UK

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. Illumina Accelerator is proud to open its first international location at... Read more